Abrogation of the RNase activity of E
Classical swine fever virus (CSFV)
Erns RNase activity
Pestivirus
humoral response
type I IFN
viral attenuation
viral persistence
viral replication
viral transmission
Journal
Virulence
ISSN: 2150-5608
Titre abrégé: Virulence
Pays: United States
ID NLM: 101531386
Informations de publication
Date de publication:
12 2021
12 2021
Historique:
entrez:
2
8
2021
pubmed:
3
8
2021
medline:
28
1
2022
Statut:
ppublish
Résumé
The prevalence of low virulence classical swine fever virus (CSFV) strains makes viral eradication difficult in endemic countries. However, the determinants for natural CSFV attenuation and persistence in the field remain unidentified. The aim of the present study was to assess the role of the RNase activity of CSFV E
Identifiants
pubmed: 34339338
doi: 10.1080/21505594.2021.1959715
pmc: PMC8331007
doi:
Substances chimiques
Ribonucleases
EC 3.1.-
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2037-2049Références
Vet Microbiol. 2017 Mar;201:103-112
pubmed: 28284595
Virus Res. 2009 Mar;140(1-2):15-23
pubmed: 19041350
J Clin Microbiol. 2001 Mar;39(3):906-12
pubmed: 11230402
Emerg Microbes Infect. 2020 Dec;9(1):2180-2189
pubmed: 32962557
Infect Genet Evol. 2012 Oct;12(7):1405-12
pubmed: 22580241
Virus Res. 2020 Jan 15;276:197809
pubmed: 31715204
Vet Microbiol. 1986 Jul;12(2):101-8
pubmed: 2428160
Sci Rep. 2018 May 29;8(1):8226
pubmed: 29844335
Virology. 2005 Sep 30;340(2):265-76
pubmed: 16043207
Adv Virus Res. 2015;93:47-160
pubmed: 26111586
Vet Microbiol. 2019 Apr;231:139-146
pubmed: 30955801
Xenotransplantation. 2001 Feb;8(1):48-61
pubmed: 11208191
BMC Vet Res. 2019 Jul 15;15(1):247
pubmed: 31307464
J Virol. 1999 Dec;73(12):10224-35
pubmed: 10559339
J Virol. 2014 Jul;88(13):7235-43
pubmed: 24741078
J Virol. 1998 Jan;72(1):151-7
pubmed: 9420210
Cell Mol Life Sci. 2021 Feb;78(4):1423-1444
pubmed: 33084946
Virus Res. 2020 Nov;289:198151
pubmed: 32898613
J Virol Methods. 2005 Dec;130(1-2):36-44
pubmed: 16055202
PLoS One. 2015 May 04;10(5):e0125692
pubmed: 25938664
J Vet Diagn Invest. 2015 Jul;27(4):449-60
pubmed: 26179095
J Virol. 1998 Jun;72(6):4737-45
pubmed: 9573238
PLoS Pathog. 2013;9(6):e1003412
pubmed: 23785283
Science. 1993 Aug 27;261(5125):1169-71
pubmed: 8356450
Vet Med Sci. 2021 Jan;7(1):164-174
pubmed: 32781492
Vet Microbiol. 1984 Apr;9(2):113-20
pubmed: 6375112
Res Vet Sci. 1972 Jan;13(1):46-51
pubmed: 4336054
Vet Immunol Immunopathol. 2012 Nov 15;150(1-2):36-46
pubmed: 22959286
Transbound Emerg Dis. 2017 Dec;64(6):2013-2022
pubmed: 28158921
J Virol. 2007 Apr;81(7):3327-38
pubmed: 17215285
J Virol. 2002 Aug;76(16):8494-503
pubmed: 12134054
Vet Immunol Immunopathol. 1992 Jan 31;30(4):319-27
pubmed: 1372135
Arch Virol. 1990;111(3-4):213-25
pubmed: 1693844
Cytokine Growth Factor Rev. 2016 Jun;29:53-62
pubmed: 27021825
J Virol. 2020 Jan 6;94(2):
pubmed: 31645448
Adv Virus Res. 1996;47:53-118
pubmed: 8895831
Immunology. 2004 May;112(1):28-37
pubmed: 15096181
PLoS One. 2016 Feb 26;11(2):e0149469
pubmed: 26919741
J Vet Med B Infect Dis Vet Public Health. 2004 Aug;51(6):260-2
pubmed: 15458487
J Gen Virol. 1996 Nov;77 ( Pt 11):2737-45
pubmed: 8922467